Cardiff Oncology
CRDF
CRDF
62 hedge funds and large institutions have $6.47M invested in Cardiff Oncology in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less capital invested
Capital invested by funds: $12.1M → $6.47M (-$5.61M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $76K
Holders
62
Holding in Top 10
–
Calls
–
Puts
$76K
Top Buyers
| 1 | +$1.92M | |
| 2 | +$205K | |
| 3 | +$101K | |
| 4 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$72.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$49.4K |
Top Sellers
| 1 | -$193K | |
| 2 | -$104K | |
| 3 | -$95.3K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$88.4K |
| 5 |
D.E. Shaw & Co
New York
|
-$38K |